Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 1,839,874	$ 4,558,430	$ 4,389,355	$ 8,751,992
General and administrative	1,061,793	1,784,914	2,342,226	3,445,448
Change in fair value of related party note	169,414		169,414
Operating loss	(3,071,081)	(6,343,344)	(6,900,995)	(12,197,440)
Other income, net:
Interest income, net	38,360	146,389	54,979	314,444
Other income, net	330,915		330,915
Net loss	$ (2,701,806)	$ (6,196,955)	$ (6,515,101)	$ (11,882,996)
Per common share data:
Basic net loss per common share	$ (0.07)	$ (0.18)	$ (0.18)	$ (0.35)
Diluted net loss per common share	$ (0.07)	$ (0.18)	$ (0.18)	$ (0.35)
Weighted average number of common shares outstanding, basic	37,142,021	34,409,064	35,892,468	34,189,214
Weighted average number of common shares outstanding, diluted	37,142,021	34,409,064	35,892,468	34,189,214
Other comprehensive loss:
Foreign currency translation loss	$ (225,595)	$ (28,008)	$ (180,428)	$ (109,343)
Comprehensive loss	$ (2,927,401)	$ (6,224,963)	$ (6,695,529)	$ (11,992,339)